The LILRB family in hematologic malignancies: prognostic associations, mechanistic considerations, and therapeutic implications
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
The LILRB family in hematologic malignancies: prognostic associations, mechanistic considerations, and therapeutic implications ; volume:12 ; number:1 ; day:19 ; month:12 ; year:2024 ; pages:1-12 ; date:12.2024
Biomarker Research ; 12, Heft 1 (19.12.2024), 1-12, 12.2024
- Urheber
-
Hodges, Alan
Dubuque, Rachel
Chen, Shu-Hsia
Pan, Ping-Ying
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40364-024-00705-7
- URN
-
urn:nbn:de:101:1-2503020602441.924560644836
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:19 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hodges, Alan
- Dubuque, Rachel
- Chen, Shu-Hsia
- Pan, Ping-Ying
- SpringerLink (Online service)
Ähnliche Objekte (12)
Hematologic malignancies
Hematologic malignancies : acute leukemias ; with 51 tables
COVID-19 in Hematologic Malignancies: Big Challenges
Targeting CD22 for B-cell hematologic malignancies
Biological relevance of alternative splicing in hematologic malignancies
Genomic testing for germline predisposition to hematologic malignancies
Antifungal Stewardship Interventions in Patients with Hematologic Malignancies
CAR-T cell combination therapies in hematologic malignancies
Immunotherapy in hematologic malignancies: past, present, and future
Therapeutic dendritic cell cancer vaccines in hematologic malignancies
Targeting the integrated stress response in hematologic malignancies
Bispecific Antibodies in the Treatment of Hematologic Malignancies
Hematologic malignancies
Hematologic malignancies : acute leukemias ; with 51 tables
COVID-19 in Hematologic Malignancies: Big Challenges
Targeting CD22 for B-cell hematologic malignancies
Biological relevance of alternative splicing in hematologic malignancies
Genomic testing for germline predisposition to hematologic malignancies
Antifungal Stewardship Interventions in Patients with Hematologic Malignancies
CAR-T cell combination therapies in hematologic malignancies
Immunotherapy in hematologic malignancies: past, present, and future
Therapeutic dendritic cell cancer vaccines in hematologic malignancies
Targeting the integrated stress response in hematologic malignancies
Bispecific Antibodies in the Treatment of Hematologic Malignancies
Hematologic malignancies
Hematologic malignancies : acute leukemias ; with 51 tables
COVID-19 in Hematologic Malignancies: Big Challenges
Targeting CD22 for B-cell hematologic malignancies
Biological relevance of alternative splicing in hematologic malignancies
Genomic testing for germline predisposition to hematologic malignancies
Antifungal Stewardship Interventions in Patients with Hematologic Malignancies
CAR-T cell combination therapies in hematologic malignancies
Immunotherapy in hematologic malignancies: past, present, and future
Therapeutic dendritic cell cancer vaccines in hematologic malignancies
Targeting the integrated stress response in hematologic malignancies